Co-Authors
This is a "connection" page, showing publications co-authored by Kevin Bouiller and François Goehringer.
Connection Strength
0.115
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? J Infect. 2020 Nov; 81(5):816-846.
Score: 0.056